<SEC-DOCUMENT>0001493152-24-037142.txt : 20240919
<SEC-HEADER>0001493152-24-037142.hdr.sgml : 20240919
<ACCEPTANCE-DATETIME>20240919165738
ACCESSION NUMBER:		0001493152-24-037142
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240919
DATE AS OF CHANGE:		20240919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ocean Power Technologies, Inc.
		CENTRAL INDEX KEY:			0001378140
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRIC SERVICES [4911]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				222535818
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275843
		FILM NUMBER:		241311065

	BUSINESS ADDRESS:	
		STREET 1:		28 ENGELHARD DRIVE
		STREET 2:		SUITE B
		CITY:			MONROE TOWNSHIP
		STATE:			NJ
		ZIP:			08831
		BUSINESS PHONE:		609-730-0400

	MAIL ADDRESS:	
		STREET 1:		28 ENGELHARD DRIVE
		STREET 2:		SUITE B
		CITY:			MONROE TOWNSHIP
		STATE:			NJ
		ZIP:			08831

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ocean Power Technologies, INc.
		DATE OF NAME CHANGE:	20061012
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>form424b5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
Pursuant to Rule 424(b)(5)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-275843</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Supplement
No. 2 to Prospectus Supplement dated March 21, 2024, as supplemented on August 30, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="form424b5_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to $2,928,033</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
supplement no. 2 dated September 19, 2024, or this supplement, supplements, modifies and supersedes, only to the extent indicated herein,
certain information contained in our prospectus supplement dated March 21, 2024, which we refer to as the initial prospectus supplement,
as supplemented on August 30, 2024, which we refer to as the first supplement, relating to the offer and sale, from time to time, of
<FONT STYLE="background-color: white">shares of our common stock to or through A.G.P./Alliance Global Partners, or A.G.P., acting as
our sales agent, in accordance with the terms of </FONT>a <FONT STYLE="background-color: white">sales agreement dated March 21, 2024
that we entered into with A.G.P.</FONT> This supplement should be read in conjunction with, is not complete without, and may not be delivered
or utilized except in connection with, the initial prospectus supplement and the first supplement, including all supplements thereto
and documents incorporated by reference therein. If there is any inconsistency between the information in the initial prospectus supplement,
the first supplement and this supplement, you should rely on the information in this supplement. Any information that is modified or
superseded in the initial prospectus supplement or the first supplement shall not be deemed to constitute a part of the initial prospectus
supplement or the first supplement, as applicable, except as modified or superseded by this supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sales agreement with A.G.P. provides that we may issue and sell additional shares of our common stock within the maximum amount registered
on our universal shelf registration statement on Form S-3, registration no. 333-275843, from time to time to or through A.G.P., acting
as our sales agent. However, due to the offering limitations applicable to us under General Instruction I.B.6. of Form S-3 and the aggregate
market value of our public float as of the date of the initial prospectus supplement (which was $21,026,712), the initial prospectus
supplement contemplated that we could offer and sell, from time to time, shares of our common stock having an aggregate gross sales price
of up to $7,000,000 pursuant to the initial prospectus supplement. Pursuant to the first supplement, we increased this amount to up to
$15,892,853 based upon an increase in the aggregate market value of our public float. As a result of a desire to utilize our universal
shelf registration statement for other transactions, and as a result of the offering limitations of General Instruction I.B.6. of Form
S-3, we are reducing the amount available for sale under the initial prospectus supplement, as amended and supplemented by the first
supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 13, 2024, the aggregate market value of our outstanding common stock held by non-affiliates, or our public float, was approximately
$41,236,422, which amount is based on 98,181,957 outstanding shares of common stock held by non-affiliates and a per share price of $0.42,
which was the last reported sale price of our common stock on the NYSE American on July 25, 2024. Accordingly, under the terms of the
sales agreement and based upon the prior sales of securities pursuant to General Instruction I.B.6. of Form S-3 during the 12 calendar
month period that ends on and includes the date of this supplement discussed below, we may offer and sell through the initial prospectus
supplement, as amended and supplemented by the first supplement and this supplement, shares of common stock having an aggregate offering
price of up to $2,928,033 from time to time to or through A.G.P., acting as our sales agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have sold $10,679,986 of securities pursuant to General Instruction I.B.6. of Form S-3 during the 12 calendar month period that ends
on and includes the date of this supplement. As a result of such prior sales and our reduction in the amount available for sale, as of
the date of this supplement, shares of common stock having an aggregate gross sales price of up to $2,928,033 remain available for offer
and sale under the sales agreement through the initial prospectus supplement and the first supplement, as amended and supplemented by
this supplement. If our public float subsequently increased such that we could sell additional amounts of our common stock pursuant to
General Instruction I.B.6. of Form S-3 and/or if we determine not to reallocate our universal shelf registration statement as described
above, we would file another supplement to the initial prospectus supplement prior to making any sales of common stock under the sales
agreement in excess of the amount of common stock covered by the initial prospectus supplement and the first supplement, as amended and
supplemented by this supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the NYSE American under the symbol &ldquo;OPTT.&rdquo; The last reported sale price of our common stock on
the NYSE American on September 18, 2024 was $0.19 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our common stock involves a high degree of risk. See &ldquo;Risk Factors&rdquo; in the prospectus and in our reports filed with the
Securities and Exchange Commission which are incorporated by reference therein for a discussion of information that should be considered
in connection with an investment in our common stock.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if the prospectus, as supplemented by this supplement, is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>A.G.P.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this supplement is September 19, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form424b5_001.jpg
<TEXT>
begin 644 form424b5_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !$ 2\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z\P^.W[
M1G@K]G?PX-3\5ZCMN9E;['I=MA[N[8=D3(P/5F(4>N2 3]HSX[:1^SO\+]1\
M5ZF%N+E?]'T^PW;6N[E@=D8/8<%F/95/4X!_$7XG?$[Q%\7_ !GJ'BCQ1J#Z
MAJMX^68\)$G\,<:_PHHX"C^>37M9?E[Q;YYZ17XGBYAF"PBY(:R?X'TI\9/^
M"F'Q.\?74]MX4:'P-HQ)"+9@2W;K_MS,.#_N*N/4U\S^)?B=XO\ &4CR:]XI
MUG6F8Y)U"_EG_P#0F-9&A:#J7B?5[32M(L;C4]2NI!%!:6L1DEE8] J@9)K[
M$^&__!+'XD>*M/BO/$VKZ7X/610PM9,W=RN?[RH0@^F_-?5OZI@8J]H_G_F?
M*+ZWCI.UY?E_D?'.EZYJ.B3B?3K^YL)@<B2VF:-A^(->S_#?]MKXR?#.XB:R
M\:7VK6B'FQUQS>Q,/[O[PEE'^ZRU]%>(/^"1WB2VLW?1?B#I>H70&5AO;"2V
M4GTW*\G\J^1OC)^S]XZ^ NL)8>,=#FT]921;WL9$EM<8_N2+P3_L\,.X%$*^
M$QGN)J7D_P#@A*AB\'[[3CYK_@'Z9_LS_P#!1/PC\9[RU\/^*H(_!WBJ8A(?
M,ES97CDX"QR'E&/9']@&8\5]=U_.9G'(K]0/^"=7[85UX\CC^&'C2_:YUVUA
M+:-J-PV9+N%!EH')^](B@D'J5!SRN6\#,,K5*+K4-ENO\CW\OS1U9*C7W>S_
M ,S[)^*W_)+O&/\ V!KS_P!$/7\^[_>;ZU_01\5O^27>,?\ L#7G_HAZ_GW?
M[S?6NC(_@J>J_4Y\\^.G\_T$HKTW]F_X,CX__%W1_!!U;^Q!J"3O]M^S^?L\
MN%Y,;-RYSLQU[U]G_P##H9/^BH'_ ,$?_P!T5[5;&T,/+DJRL_1GBT<%7Q$>
M>E&Z]4?G59WUSITZS6EQ+;3+R)(7*L/Q%>S?"_\ ;,^+OPIOH9-.\87VIV2$
M;M-UJ5KRW=?[N')*#_<*GWKZ6\4?\$C];M-,EE\/?$&QU.^524M;_3FM4<^G
MF+))C_OFOAKQUX%USX:^+-1\->(]/DTS6=/D\JXMI<9!QD$$<%2""".""".#
M2IUL-C4XQ:E\O\RJE'%8)J4DX_UY'[)_LH_MA>'/VF]'EMTA&B>+K&,27NCO
M)N#+P#-"W\29(!'520#U!/AO_!6[_DF_@3_L*S?^BA7YW_"7XEZM\'_B)H7B
M[196COM,N5EV!L+-'T>)O]EU+*?9J_6W]J+]GU_VS/AKX*FT'Q#;Z+9J5U6*
M>XMVE\V*:%2@ 5A@X(->!5PU/+\93JWM!W^1[U/$U,PP=2E:\U;YZGXQT5^@
M/_#HOQ!_T473?_!=)_\ %T?\.B_$'_11=-_\%TG_ ,77M?VGA/\ GY^#_P C
MQ?[,Q?\ S[_%?YGY_45<UC3CH^K7MBSB5K:9X2X& VUB,_I6_P#"GP#+\4OB
M/X=\)07B:?-K-['9K=2(76(NV-Q /->DY**YGL><HN4E%;G*45^@/_#HOQ!_
MT473?_!=)_\ %T?\.B_$'_11=-_\%TG_ ,77F_VGA/\ GY^#_P CT?[,Q?\
MS[_%?YGT%_P3(_Y-;LO^PK=_S6OK"O'_ -E7X%W?[.WPF@\'WFK0ZS-'>37/
MVJ"$Q*0Y!Q@D],5[!7Q&+G&I7G.+NFS[?"0E3H0A)6:2"BBN9^(7CBU\ ^&Y
M]2N,22_<MX,X\R0]!]!U/^.*YX0E4DH15VR\1B*6$HRKUI6C%7;)/&GCW1_
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MUN>^8Y1P>.=IPP[@5]-A<=1Q2M!V?9[GFXK UL*[R5UW1^H__!-/_DU+1/\
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<;F56/.T'IDD^]=A115U).4FV]2*:48I):'__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
